Prostate Health Market Forecast 2024-2033: Rising to USD 99.41 Billion by 2033 Driven by Telehealth Expansion, Liquid Biopsy Advancements, and ARI Pipeline Innovations

"The global prostate health market reached US$41.34 billion in 2024 and is expected to reach US$99.41 billion by 2033, growing at a CAGR of 9.1% during the forecast period of 2025-2033," according to DataM Intelligence.

The prostate health market comprises pharmaceutical and med-tech leaders offering diagnostics, therapeutics, and surgical solutions. Companies like Novartis, Pfizer, Merck, Astellas, and Sanofi dominate with products ranging from hormonal therapies to biomarker diagnostics. Med-tech and diagnostic firms such as Johnson & Johnson, Bayer, and GSK support the market with imaging, PSA testing, and interventional devices. Viatris and Wellona Pharma are strengthening regional pipelines through generics and health supplement innovations.

Download your exclusive sample report today: https://www.datamintelligence.com/download-sample/prostate-health-market?jd

Prostate Health Market M&A & Strategic Collaborations

1. AstraZeneca Acquires Fusion Pharmaceuticals to enhance its radioligand prostate cancer pipeline with FPI 2265 targeting metastatic cases.
2. Artera-Tempus AI Prostate Test Deal brings AI-driven diagnostic capabilities to 50% of U.S. oncologists.
3. Bayer Scales Radioligand Therapy Production, boosting PSA targeted treatments in North America and Europe.

As per our analysis, these strategic alliances underscore the ongoing convergence of AI diagnostics, radiopharmaceuticals, and data-driven biotechnology investments in prostate health.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/prostate-health-market?jd

Key Growth Drivers & Emerging Opportunities in the Prostate Health Market

• Rising prostate cancer prevalence among aging populations is accelerating screening and care demand.
• Adoption of AI-enhanced imaging and PSA tests is improving early detection accuracy.
• Expansion of telehealth models and point-of-care diagnostics is boosting access to prostate health management.
• Growth in radioligand therapies and targeted treatments is fueling R&D investment and market innovation.
• Government screenings and public awareness initiatives are driving adoption in both developed and emerging regions.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=prostate-health-market?jd

Regional Market Drivers for the Prostate Health Market

North America leads with high R&D spending, advanced medical infrastructure, and widespread use of PSA screening.
Europe benefits from robust public health systems, regulatory support, and adoption of biomarker-based detection tools.
Asia-Pacific is the fastest-growing region, propelled by rising incidence, biotech expansion in China/India, and improved diagnostic access.
Latin America & MEA are emerging markets fueled by international health partnerships and moderate growth in healthcare infrastructure.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.